NCT06528496 2026-02-10N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting45 enrolled